Abstract:A six-year old Holstein cow with an eye cancer (ocular squamous cell carcinoma) involving the third eyelid and conjunctiva was submitted to photodynamic therapy using intratumoral 20% aminolevulinic acid (5-ALA -Aldrich Chemical Company, Milwaukee, USA) and a light emitting diode (LED -VET LED -MMOptics®) with wavelength between 600 and 700 nm, 2 cm diameter circular light beam, power of 150 mW, light dose of 50 J/cm 2 as a source of irradiation. Fifteen days after the experimental procedure we observed about … Show more
“…One such second-generation photosensitiser is 5-aminolevulinic acid (ALA), a naturally occurring pro-photosensitiser and precursor for the biosynthesis of heme. For therapeutic purposes, ALA is administered topically (Morton et al, 2008(Morton et al, , 2013, orally (Muller and Wilson, 2006), or intralesionally (Hage et al, 2007;Kim et al, 2012) and enters into all cells; although uptake is potentiated by transporters of beta-amino acids and GABA (Rud et al, 2000), highly expressed on some cancer cells and neurons (Zhang et al, 2013). ALA is then metabolised to the red-fluorescent photosensitiser protoporphyrin IX (PpIX, absorption 635 nm) and finally to non-fluorescent heme (Ajioka et al, 2006, Allison andMoghissi 2013a).…”
Section: Photosensitizers For Pdtmentioning
confidence: 99%
“…In human patients ALA has been used for the treatment of T cell lymphoma (Coors et al, 2004), basal cell carcinoma (Kim et al, 2012) squamous cell carcinoma (SCC) and other head and neck cancers (Grant, et al, 1993, Morton et al, 1996. In veterinary medicine, ALA has been used to treat SCC in a cow (Hage et al, 2007) and in cats (Bexfield et al, 2008), sarcoids in horses (Gustafson et al, 2004, Golding et al, 2017 and transitional cell carcinoma in dogs (Lucroy et al, 2003a,b). See Tables 1 and 2. The hydrophilic nature of ALA limits its ability to deeply penetrate intact skin and thereby restricts the use of topically applied ALA-PDT to the treatment of superficial diseases, where the tissue structure is disorganised.…”
Section: Photosensitizers For Pdtmentioning
confidence: 99%
“…As is the case in human patients, the smaller and less invasive tumours respond best to PDT (Magne et al, 1997). PDT has also been used to treat SCC in dogs (McCaw et al, 2000), horses (Giuliano 2008), a cow (Hage et al, 2007), snakes (Roberts WG et al,1991) and a Great Hornbill (Suedmeyer et al, 2001).…”
Section: Carcinoma In Situ / Squamous Cell Carcinoma (Scc)mentioning
confidence: 99%
“…Experience of intralesional injection of PS is very limited in animals. One study reported PDT in a cow with ocular SCC using intratumoural injection of ALA. A complete response was observed after 3 months and no relapse 12 months after the treatment (Hage et al, 2007). PDT has also been used for treatment of periocular SCC in horses.…”
Photodynamic therapy (PDT) is an evolving method of treating superficial tumours that is non-invasive and carries minimal risk of toxicity. It combines tumour-selective photosensitiser dyes, tissue oxygen and targeted illumination to generate cytotoxic reactive oxygen species (ROS) within the tumour. In addition to directly acting on tumour cells, PDT damages and restricts tumour microvasculature, and causes a local inflammatory response that stimulates an immune response against the tumour. Unlike surgery or radiotherapy, the surrounding extracellular matrix is unaffected by PDT; thus, tissue healing is excellent and PDT seldom causes scars. This, combined with the ease of light application, has made PDT a popular treatment for cancers and pre-cancerous conditions in human beings. Moreover, because photosensitiser dyes are fluorescent and selectively accumulate in tumour tissues, they can additionally be used to visualise and discriminate tumour from normal tissues, thereby improving the accuracy of tumour surgery. In veterinary practice, PDT has been used successfully for treatment of superficial squamous cell carcinomas of the feline nasal planum; urinary tract, urinary bladder and prostate neoplasia in dogs; and equine sarcoids. The purpose of this article is to provide a comparative review of the current literature on PDT in human and veterinary medicine, and to establish a basis for future development of PDT in veterinary medicine.
“…One such second-generation photosensitiser is 5-aminolevulinic acid (ALA), a naturally occurring pro-photosensitiser and precursor for the biosynthesis of heme. For therapeutic purposes, ALA is administered topically (Morton et al, 2008(Morton et al, , 2013, orally (Muller and Wilson, 2006), or intralesionally (Hage et al, 2007;Kim et al, 2012) and enters into all cells; although uptake is potentiated by transporters of beta-amino acids and GABA (Rud et al, 2000), highly expressed on some cancer cells and neurons (Zhang et al, 2013). ALA is then metabolised to the red-fluorescent photosensitiser protoporphyrin IX (PpIX, absorption 635 nm) and finally to non-fluorescent heme (Ajioka et al, 2006, Allison andMoghissi 2013a).…”
Section: Photosensitizers For Pdtmentioning
confidence: 99%
“…In human patients ALA has been used for the treatment of T cell lymphoma (Coors et al, 2004), basal cell carcinoma (Kim et al, 2012) squamous cell carcinoma (SCC) and other head and neck cancers (Grant, et al, 1993, Morton et al, 1996. In veterinary medicine, ALA has been used to treat SCC in a cow (Hage et al, 2007) and in cats (Bexfield et al, 2008), sarcoids in horses (Gustafson et al, 2004, Golding et al, 2017 and transitional cell carcinoma in dogs (Lucroy et al, 2003a,b). See Tables 1 and 2. The hydrophilic nature of ALA limits its ability to deeply penetrate intact skin and thereby restricts the use of topically applied ALA-PDT to the treatment of superficial diseases, where the tissue structure is disorganised.…”
Section: Photosensitizers For Pdtmentioning
confidence: 99%
“…As is the case in human patients, the smaller and less invasive tumours respond best to PDT (Magne et al, 1997). PDT has also been used to treat SCC in dogs (McCaw et al, 2000), horses (Giuliano 2008), a cow (Hage et al, 2007), snakes (Roberts WG et al,1991) and a Great Hornbill (Suedmeyer et al, 2001).…”
Section: Carcinoma In Situ / Squamous Cell Carcinoma (Scc)mentioning
confidence: 99%
“…Experience of intralesional injection of PS is very limited in animals. One study reported PDT in a cow with ocular SCC using intratumoural injection of ALA. A complete response was observed after 3 months and no relapse 12 months after the treatment (Hage et al, 2007). PDT has also been used for treatment of periocular SCC in horses.…”
Photodynamic therapy (PDT) is an evolving method of treating superficial tumours that is non-invasive and carries minimal risk of toxicity. It combines tumour-selective photosensitiser dyes, tissue oxygen and targeted illumination to generate cytotoxic reactive oxygen species (ROS) within the tumour. In addition to directly acting on tumour cells, PDT damages and restricts tumour microvasculature, and causes a local inflammatory response that stimulates an immune response against the tumour. Unlike surgery or radiotherapy, the surrounding extracellular matrix is unaffected by PDT; thus, tissue healing is excellent and PDT seldom causes scars. This, combined with the ease of light application, has made PDT a popular treatment for cancers and pre-cancerous conditions in human beings. Moreover, because photosensitiser dyes are fluorescent and selectively accumulate in tumour tissues, they can additionally be used to visualise and discriminate tumour from normal tissues, thereby improving the accuracy of tumour surgery. In veterinary practice, PDT has been used successfully for treatment of superficial squamous cell carcinomas of the feline nasal planum; urinary tract, urinary bladder and prostate neoplasia in dogs; and equine sarcoids. The purpose of this article is to provide a comparative review of the current literature on PDT in human and veterinary medicine, and to establish a basis for future development of PDT in veterinary medicine.
“…Many methods have been used in the handling of these wounds, from the use of local anti-septic and antibiotics up to systemic antibiotics, however, many of these wounds tend if to become chronic. In recent years researchers have investigated the effect of the photodynamic therapy in the treatment of cancers (Luckroy, 2002;Hage et al 2004 and2007;Qiang et al, 2006), dermatological diseases (Ceburkov and Gollnick, 2000;Qiang et al, 2006), to control infections caused by bacteria (Lambrechts et al 2005, Carvalho et al 2006) and fungi (Bliss et al 2004) , as well as in the treatment of cutaneous wounds (Hamblin et al 2001, Jayasree et al 2001). This technique consists of the application of a topic, intravenous or oral photosensitizer that tend to concentrate preferentially in the injured tissue and subsequent irradiation with light of a specific wave length that, in the presence of molecular oxygen unchains a photochemical reaction, inducing the release of free radicals and resulting into the death of these cells among other local effects.…”
Photodynamic Therapy (PDT) is an emerging and promising therapeutic modality for treatment of a wide variety of malignant and nononcologic tumors, as well as in the treatment of infected skin ulcers. This study evaluated the effectiveness of the PDT to treat a chronic skin wound that had been already subjected to several clinical and surgical type treatments in a dog. The animal with an infected chronic skin wound with 8 cm diameter in the left leg received an injection of an aqueous solution of 1% methylene blue (MB) with 2% lidocaine into the lesion. After MB injection the wound was irradiated using a LED (LED-VET MMOptics®) with a wavelength between 600 and 700 nm, 2 cm diameter circular light beam, of 150 mW of power, light dose of 50 J/cm 2 . After 3 and 6 weeks PDT was repeated and the wound was re-evaluated. Complete healing was achieved 10 weeks after the first procedure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.